Skip to content

CorMedix CRMD Asset turnover

Asset turnover at other companies

Pfizer logo
PfizerPFE
0.3×0.0×
Merck & Co. logo
Merck & Co.MRK
0.5×0.0×
Merit Medical Systems logo
Merit Medical SystemsMMSI
0.6×0.0×
ITG
Integer HoldingsITGR
0.6×0.0×
IAR
Integra LifeSciencesIART
0.4×0.0×
Abbott logo
AbbottABT
0.5×-0.1×

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

Based on trailing twelve months.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's asset turnover?
CorMedix (CRMD) reported asset turnover of 0.8× in Q1 2026.
How has CorMedix's asset turnover changed year-over-year?
CorMedix's asset turnover increased by 9.3% year-over-year, from 0.8× to 0.8×.
What is the long-term trend for CorMedix's asset turnover?
Over 4 years (2020 to 2025), CorMedix's asset turnover has grown at a 222.5% compound annual growth rate (CAGR), from 0× to 0.7×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.